Literature DB >> 28898226

After Myriad, what makes a gene patent claim 'markedly different' from nature?

Mateo Aboy1, Johnathon Liddicoat1, Kathleen Liddell1, Matthew Jordan1, Cristina Crespo1.   

Abstract

Year:  2017        PMID: 28898226     DOI: 10.1038/nbt.3953

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

Review 1.  The History of Patenting Genetic Material.

Authors:  Jacob S Sherkow; Henry T Greely
Journal:  Annu Rev Genet       Date:  2015-10-06       Impact factor: 16.830

Review 2.  The fate and future of patents on human genes and genetic diagnostic methods.

Authors:  Isabelle Huys; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Rev Genet       Date:  2012-05-18       Impact factor: 53.242

3.  Myriad ruling causes confusion.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2013-06-20       Impact factor: 49.962

4.  Patent landscaping for life sciences innovation: toward consistent and transparent practices.

Authors:  Tania Bubela; E Richard Gold; Gregory D Graff; Daniel R Cahoy; Dianne Nicol; David Castle
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

5.  Not quite a myriad of gene patents.

Authors:  Gregory D Graff; Devon Phillips; Zhen Lei; Sooyoung Oh; Carol Nottenburg; Philip G Pardey
Journal:  Nat Biotechnol       Date:  2013-05       Impact factor: 54.908

6.  The changing life science patent landscape.

Authors:  Arti K Rai; Jacob S Sherkow
Journal:  Nat Biotechnol       Date:  2016-03       Impact factor: 54.908

7.  Myriad's impact on gene patents.

Authors:  Mateo Aboy; Kathleen Liddell; Johnathon Liddicoat; Cristina Crespo
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

8.  Persistent confusion and controversy surrounding gene patents.

Authors:  Christi J Guerrini; Mary A Majumder; Amy L McGuire
Journal:  Nat Biotechnol       Date:  2016-02       Impact factor: 54.908

9.  Dolly and Alice.

Authors:  Dan L Burk
Journal:  J Law Biosci       Date:  2015-10-16

10.  Transparency tools in gene patenting for informing policy and practice.

Authors:  Osmat A Jefferson; Deniz Köllhofer; Thomas H Ehrich; Richard A Jefferson
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

  10 in total
  3 in total

1.  Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Authors:  Mateo Aboy; Cristina Crespo; Kathleen Liddell; Johnathon Liddicoat; Matthew Jordan
Journal:  Nat Biotechnol       Date:  2018-12-06       Impact factor: 54.908

2.  European patent protection for medical uses of known products and drug repurposing.

Authors:  Mateo Aboy; Kathleen Liddell; Matthew Jordan; Cristina Crespo; Johnathon Liddicoat
Journal:  Nat Biotechnol       Date:  2022-04       Impact factor: 54.908

3.  Opening options for material transfer.

Authors:  Linda Kahl; Jennifer Molloy; Nicola Patron; Colette Matthewman; Jim Haseloff; David Grewal; Richard Johnson; Drew Endy
Journal:  Nat Biotechnol       Date:  2018-10-11       Impact factor: 54.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.